Evidence map›Paper›PMID 29299688›Full record

ArticleJournal of neural transmission (Vienna, Austria : 1996)2018

Gamma-aminobutyric acid (GABA) receptors GABRA4, GABRE, and GABRQ gene polymorphisms and risk for migraine.

Elena García-Martín, Gara Esguevillas, Mercedes Serrador, Hortensia Alonso-Navarro, Francisco Navacerrada, Gemma Amo, Esteban García-Albea, José A G Agúndez, Félix Javier Jiménez-Jiménez

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neural transmission (Vienna, Austria : 1996), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Vitamin D receptor and binding protein genes variants in patients with migraine.Annals of clinical and translational neurology · 2023
    Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Elena García-MartínDepartment of Pharmacology, University of Extremadura, Cáceres, Spain.
Gara EsguevillasDepartment of Pharmacology, University of Extremadura, Cáceres, Spain.
Mercedes SerradorDepartment of Family Medicine, Hospital "Príncipe de Asturias", Universidad de Alcalá, Alcalá de Henares, Madrid, Spain.
Hortensia Alonso-NavarroSection of Neurology, Hospital Universitario del Sureste, Arganda del Rey, C/Marroquina 14, 3° B, 28030, Madrid, Spain.
Francisco NavacerradaSection of Neurology, Hospital Universitario del Sureste, Arganda del Rey, C/Marroquina 14, 3° B, 28030, Madrid, Spain.
Gemma AmoDepartment of Pharmacology, University of Extremadura, Cáceres, Spain.
Esteban García-AlbeaDepartment of Medicine-Neurology, Hospital "Príncipe de Asturias", Universidad de Alcalá, Alcalá de Henares, Madrid, Spain.
José A G AgúndezDepartment of Pharmacology, University of Extremadura, Cáceres, Spain.
Félix Javier Jiménez-JiménezSection of Neurology, Hospital Universitario del Sureste, Arganda del Rey, C/Marroquina 14, 3° B, 28030, Madrid, Spain. fjavier.jimenez@salud.madrid.org.ORCID 0000-0002-7558-7323
Universidad de Alcalá · ESInstituto de Salud Carlos III · ESUniversidad de Extremadura · ESHospital Universitario Príncipe de Asturias · ES

Funding

Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Spain PI12/00241Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Spain PI12/00324Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Spain PI15/00303Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Spain RETICS RD12/0013/0002Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Spain RETICS RD16/0006/0004Junta de Extremadura, Mérida, Spain GR15026Junta de Extremadura, Mérida, SPAIN IB16170
6 · The paper itself

Abstract

Several biochemical, pharmacological, neurophysiological and experimental data suggest a possible role of gamma-aminobutyric acid (GABA) in the pathogenesis of migraine. We investigated the possible association of the most common single nucleotide polymorphisms (SNPs) in the GABA receptor alpha4 (GABRA4), epsilon (GABRE), and theta (GABRQ) genes with the risk for migraine. A TaqMan-based qPCR assay designed to detect the most common SNPs in the GABRA4 (rs2229940), GABRE (rs1139916), and GABRQ (rs3810651) was performed in 197 migraine patients and 394 age- and gender-matched controls. The possible influence of gender, age at onset of migraine, positive family history of migraine, presence or absence of aura, and triggering of migraine by ethanol on the frequency of the genotypes was also studied. The frequency of GABRE rs1139916AA genotype was significantly lower in the migraine group only in the female gender, but the differences did not reach statistical significance after correction for multiple comparisons. The mean ± SD age at onset of migraine was significantly lower in patients with GABRQ rs3810651AA as compared with the other two genotypes. Positive family history of migraine and presence or absence of aura did not influence the frequencies of the genotypes of the three SNPs studied. Triggering of migraine by ethanol was significantly less frequent in patients with GABRA4 rs2229940GG and more frequent in patients with GABRQ 3810651TT genotype, but the differences lost statistical significance after correction for multiple comparisons. GABRQ rs3810651 could play a role in the modification of age at onset of migraine.

Indexed as

AdultAge of OnsetFemaleGenetic Predisposition to DiseaseGenotypeHumansMaleMiddle AgedMigraine DisordersPolymorphism, Single NucleotideReceptors, GABA-ARisk FactorsGABRA4 protein, humanGABRE protein, humanGABRQ protein, humanReceptors, GABA-AGABAGABA receptor genesGenetic polymorphismsMigraineRisk factors

Identifiers

PMID29299688
OpenAlexW2782448098

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.